Search
Descriptor English: Antiretroviral Therapy, Highly Active
Descriptor Spanish: Terapia Antirretroviral Altamente Activa
Descriptor tratamiento antirretrovírico de gran actividad
Entry term(s) TARGA
Scope note: Pautas farmacológicas que se aplican a pacientes con INFECCIONES POR VIH, que suprimen de forma radical la replicación del VIH. Las pautas implican generalmente la administración de tres o más fármacos diferentes, incluido un inhibidor de la proteasa.
Descriptor Portuguese: Terapia Antirretroviral de Alta Atividade
Descriptor French: Thérapie antirétrovirale hautement active
Entry term(s): HAART
Highly Active Antiretroviral Therapy
Tree number(s): E02.319.310.075
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D023241
Scope note: Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
Annotation: IM when general; NIM when with specific drugs
Allowable Qualifiers: AE adverse effects
CL classification
EC economics
ES ethics
HI history
IS instrumentation
MO mortality
MT methods
NU nursing
PX psychology
SN statistics & numerical data
ST standards
TD trends
VE veterinary
Previous Indexing: Anti-HIV Agents/therapeutic use (1997-2000)
Drug Therapy, Combination (1997-2000)
Public MeSH Note: 2001
History Note: 2001
Entry Version: ANTIRETROVIRAL THER HIGHLY ACTIVE
Related: Anti-HIV Agents MeSH
DeCS ID: 35395
Unique ID: D023241
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2001/01/01
Date of Entry: 2000/06/21
Revision Date: 2002/07/02
Antiretroviral Therapy, Highly Active - Preferred
Concept UI M0360830
Scope note Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
Preferred term Antiretroviral Therapy, Highly Active
Entry term(s) HAART
Highly Active Antiretroviral Therapy



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey